Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register
- PMID: 17980576
- DOI: 10.1016/j.ejca.2007.09.018
Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register
Abstract
Italy was an important producer of raw asbestos until 1992 (when it was banned) and it is now experiencing severe public health consequences due to large-scale industrial use of asbestos in shipbuilding and repair, asbestos-cement production, railways, buildings, chemicals and many other industrial sectors. Latency of malignant mesothelioma generally shows a large variability and the relationship with the modality of asbestos exposure is still not fully clarified. We present an analysis of latency period among the case list collected by the Italian mesothelioma register (ReNaM) in the period of diagnosis 1993-2001 (2544 malignant mesothelioma (MM) cases with asbestos exposure history). Exposure is assessed retrospectively by interview. Statistical univariate analyses were performed to estimate median and variability measures of latency time by anatomical site, gender and diagnosis period. The role of diagnostic confidence level, the morphology of the tumour and the modalities of asbestos exposure were verified in a regression multivariate model. We found a median latency period of 44.6 years increasing in recent years with a linear trend. Anatomical site, gender and morphology were not relevant for MM latency time whereas a shorter latency period was documented among occupationally exposed subjects (43 years) with respect to environmentally and household exposed ones (48 years).
Similar articles
-
[Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia].Med Lav. 2001 Jul-Aug;92(4):249-62. Med Lav. 2001. PMID: 11676187 Italian.
-
Incidence of extrapleural malignant mesothelioma and asbestos exposure, from the Italian national register.Occup Environ Med. 2010 Nov;67(11):760-5. doi: 10.1136/oem.2009.051466. Epub 2010 Aug 25. Occup Environ Med. 2010. PMID: 20798014
-
Malignant mesothelioma in Italy, 1997.Am J Ind Med. 2004 Jan;45(1):55-62. doi: 10.1002/ajim.10313. Am J Ind Med. 2004. PMID: 14691969
-
Epidemiology of pleural mesothelioma in Italy.Lung Cancer. 2004 Aug;45 Suppl 1:S25-7. doi: 10.1016/j.lungcan.2004.04.011. Lung Cancer. 2004. PMID: 15261429 Review.
-
Mesothelioma associated with environmental exposures.Med Lav. 2005 Jul-Aug;96(4):330-7. Med Lav. 2005. PMID: 16457429 Review.
Cited by
-
Mesothelioma incidence surveillance systems and claims for workers' compensation. Epidemiological evidence and prospects for an integrated framework.BMC Public Health. 2012 Jul 5;12:314. doi: 10.1186/1471-2458-12-314. BMC Public Health. 2012. PMID: 22545679 Free PMC article.
-
The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure.Occup Environ Med. 2018 Apr;75(4):254-262. doi: 10.1136/oemed-2016-104119. Epub 2017 Dec 21. Occup Environ Med. 2018. PMID: 29269563 Free PMC article.
-
The health impact of nonoccupational exposure to asbestos: what do we know?Eur J Cancer Prev. 2009 Nov;18(6):489-503. doi: 10.1097/CEJ.0b013e32832f9bee. Eur J Cancer Prev. 2009. PMID: 19617842 Free PMC article. Review.
-
Human Exposure to Asbestos in Central Asian Countries and Health Effects: A Narrative Review.Med Lav. 2024 Dec 19;115(6):e2024042. doi: 10.23749/mdl.v115i6.15453. Med Lav. 2024. PMID: 39697085 Free PMC article.
-
Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients.Radiol Oncol. 2012 Jun;46(2):136-44. doi: 10.2478/v10019-012-0032-0. Epub 2012 May 30. Radiol Oncol. 2012. PMID: 23077450 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical